A groundbreaking shift in our drug policy has taken place, as the regulators permit the use of psilocybin mushrooms for therapeutic applications. Previously, these substances were severely restricted, but a increasing body of research suggests they potentially offer aid for psychological illnesses like anxiety. The new policy represents a major ste